The Company has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Annual Report”) within the time period prescribed. During the final stages of the 10-K preparation process, complex issues related to the Company’s acquisition of Advent BioServices were encountered, including due to differences in UK GAAP and US GAAP.
The Company is working to file the 2025 Annual Report as soon as is reasonably practicable
Market Data 
Markets 
AI
